These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 26110560

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
    Wegener A, Deboux C, Bachelin C, Frah M, Kerninon C, Seilhean D, Weider M, Wegner M, Nait-Oumesmar B.
    Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination.
    Mason JL, Jones JJ, Taniike M, Morell P, Suzuki K, Matsushima GK.
    J Neurosci Res; 2000 Aug 01; 61(3):251-62. PubMed ID: 10900072
    [Abstract] [Full Text] [Related]

  • 7. Olig2 Silence Ameliorates Cuprizone-Induced Schizophrenia-Like Symptoms in Mice.
    Liu H, Zhai J, Wang B, Fang M.
    Med Sci Monit; 2017 Oct 09; 23():4834-4840. PubMed ID: 28989170
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Statin therapy inhibits remyelination in the central nervous system.
    Miron VE, Zehntner SP, Kuhlmann T, Ludwin SK, Owens T, Kennedy TE, Bedell BJ, Antel JP.
    Am J Pathol; 2009 May 09; 174(5):1880-90. PubMed ID: 19349355
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Olig2-enriched exosomes: A novel therapeutic approach for cuprizone-induced demyelination.
    Li YJ, He J, Zhang QH, Wei B, Tao X, Yu CC, Shi LN, Wang ZH, Li X, Wang LB.
    Neuroscience; 2024 Sep 13; 555():41-51. PubMed ID: 39033991
    [Abstract] [Full Text] [Related]

  • 12. Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.
    Clarner T, Parabucki A, Beyer C, Kipp M.
    J Neuroendocrinol; 2011 Jul 13; 23(7):601-11. PubMed ID: 21507085
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of microglial ablation and mesenchymal stem cell transplantation on a cuprizone-induced demyelination model.
    Tahmasebi F, Pasbakhsh P, Barati S, Madadi S, Kashani IR.
    J Cell Physiol; 2021 May 13; 236(5):3552-3564. PubMed ID: 32996165
    [Abstract] [Full Text] [Related]

  • 20. Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
    Nakajima M, Kawamura T, Tokui R, Furuta K, Sugino M, Nakanishi M, Okuyama S, Furukawa Y.
    Brain Res; 2013 Nov 06; 1537():340-9. PubMed ID: 24070676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.